文献速递胸部CT

偶发小纯磨玻璃结节生长轨迹与危险分层

Growth Patterns and Risk Stratification of Incidental Small Pure Ground-Glass Nodules across Independent Cohorts.
PubMed 文献 · Radiology · 2026-01-01

该回顾性研究纳入两中心910例患者共1206个<10mm偶发小纯磨玻璃结节,均接受5年年度CT随访。通过潜类别轨迹模型识别出一类进行性生长模式,家族肺癌史在两中心均为其独立危险因素。

要点

  • 小纯磨玻璃结节中出现血管征和气泡透亮影提示生长风险升高。
  • 家族肺癌史是进行性生长模式的稳定独立危险因素,报告应注明。
  • 多数小纯磨玻璃结节5年内保持稳定,可避免过度干预。

核心结论

  • 在两个独立临床队列中识别出与家族肺癌史相关的小纯磨玻璃结节进行性生长模式。
  • 中心1中气泡透亮影、血管征和家族史是结节生长的独立危险因素。
  • 中心2中血管征和家族史与结节生长独立相关。

研究设计与样本

  • 回顾性研究,纳入2017年6月至2019年6月温州医科大学附属台州医院和附属第一医院常规体检低剂量CT检出的小纯磨玻璃结节。
  • 共910例患者(中位年龄47岁,IQR 41-57岁;男422例,女488例;1206个结节),中心1有754个结节,中心2有452个结节。
  • 所有患者接受每年CT随访共5年,结节层面分析使用混合效应模型并以个体患者为随机效应。
  • 采用潜类别轨迹模型识别生长模式,多变量混合效应logistic回归评价独立危险因素。
  • 小纯磨玻璃结节定义为直径小于10mm,参考标准为随访CT上的结节生长。

关键影像表现/征象

  • 中心1中8.6%(65/754)的小纯磨玻璃结节在随访中出现生长。
  • 气泡透亮影是中心1结节生长的影像学危险因素,HR为2.39(P=.02)。
  • 血管征在中心1(HR=2.98,P=.006)和中心2(HR=2.98,P=.04)均与结节生长相关。
  • 潜类别轨迹模型在两中心均识别出一类区别于稳定结节的进行性生长轨迹。

诊断标准与关键数值

  • 中心1:气泡透亮影HR=2.39(P=.02),血管征HR=2.98(P=.006),家族肺癌史HR=2.83(P=.02)。
  • 中心2:血管征HR=2.98(P=.04),家族肺癌史HR=3.94(P=.01)。
  • 进行性生长模式:中心1家族史OR=4.23(P=.01),中心2家族史OR=5.01(P=.003)。
  • 中心2血管征对进行性生长模式的OR=4.38(P=.01)。

临床应用与阅片要点

  • 报告小纯磨玻璃结节时应描述有无血管穿行征和气泡透亮影。
  • 询问并记录家族肺癌史,有助于识别可能进行性生长的病例。
  • 多数小纯磨玻璃结节5年随访稳定,年度CT随访策略总体安全。

局限性

  • 回顾性设计,可能存在选择偏倚。
  • 研究人群来自两家单一地区医院,外推性受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background The widespread adoption of low-dose CT has increased the detection of small pure ground-glass nodules (pGGNs). The management of this type of nodule currently remains a clinical challenge. Purpose To characterize long-term growth trajectories of incidental small pGGNs, identify risk factors for nodule growth and progression, and assess the reproducibility of these findings in an independent cohort. Materials and Methods This retrospective study included patients with incidental small pGGNs (<10 mm) detected with low-dose chest CT during routine wellness assessments at Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University (center 1) and the First Affiliated Hospital of Wenzhou Medical University (center 2) from June 2017 to June 2019. All patients underwent annual CT follow-up for 5 years. To adjust for intrapatient clustering, all nodule-level and risk factor analyses used mixed-effects models with the individual patient as a random effect. Latent class trajectory modeling was used to identify growth patterns, with independent risk factors evaluated via multivariable mixed-effects logistic regression. Results This study included 910 patients (median age, 47 years [IQR, 41-57 years]; 422 men, 488 women; 1206 pGGNs). At center 1 (n = 754 pGGNs), 8.6% (65 of 754) of nodules exhibited growth, and bubble lucency (hazard ratio = 2.39; P = .02), vessel sign (hazard ratio = 2.98; P = .006), and family history of lung cancer (hazard ratio = 2.83; P = .02) were independent risk factors associated with nodule growth. At center 2 (n = 452 pGGNs), vessel sign (hazard ratio = 2.98; P = .04) and family history (hazard ratio = 3.94; P = .01) were associated with nodule growth. Latent class trajectory modeling identified a distinct progressive growth pattern in patients from both centers, for which family history of lung cancer was an independent risk factor at center 1 (odds ratio = 4.23; P = .01) and center 2 (odds ratio = 5.01; P =.003), with vessel sign being another risk factor at center 2 (odds ratio = 4.38; P = .01). Conclusion Across two independent clinical cohorts, a distinct progressive growth pattern associated with family history of lung cancer was identified in patients with incidental pGGNs detected at low-dose chest CT. © The Author(s) 2026. Published by the Radiological Society of North America under a CC BY 4.0 license. Supplemental material is available for this article. See also the editorial by Lee and Um in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Liu, Fu, Ye, et al. Growth Patterns and Risk Stratification of Incidental Small Pure Ground-Glass Nodules across Independent Cohorts. Radiology. 2026. PMID: 42640190. doi:10.1148/radiol.253139

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。